DRAP Mandates 2D Barcodes & Syringe Upgrades
A new era of healthcare transparency begins. The Drug Regulatory Authority of Pakistan (DRAP) has established critical regulatory timelines to safeguard public health: The Pakistan Pharmaceutical Manufacturers Association (PPMA) strongly welcomes these landmark regulatory milestones, standing united with DRAP in this definitive victory for national patient safety and pharmaceutical innovation.
DRAP Mandates 2D Barcodes & Syringe Upgrades Read More »









